HALOZYME THERAPEUTICS, INC. Public Float
HALOZYME THERAPEUTICS, INC. (HALO) had Public Float of $4.50 billion as of 2025-06-30, per its 10-K filed 2026-02-17.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-17
- 2025-06-30: Entity Public Float $4.50B.
- 2024-06-30: Entity Public Float $4.90B.
- 2023-06-30: Entity Public Float $3.50B.
- 2022-06-30: Entity Public Float $5.10B.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $4.50B 10-K · filed 2026-02-17 |
| 2024-06-30 | $4.90B 10-K · filed 2025-02-18 |
| 2023-06-30 | $3.50B 10-K · filed 2024-02-20 |
| 2022-06-30 | $5.10B 10-K · filed 2023-02-21 |
| 2021-06-30 | $5.60B 10-K · filed 2022-02-22 |
| 2020-06-30 | $2.90B 10-K · filed 2021-02-23 |
| 2019-06-30 | $2.50B 10-K · filed 2020-02-24 |
| 2018-06-30 | $2.10B 10-K · filed 2019-02-21 |
| 2017-06-30 | $1.30B 10-K · filed 2018-02-20 |
| 2016-06-30 | $1.10B 10-K · filed 2017-02-28 |
| 2015-06-30 | $2.40B 10-K · filed 2016-02-29 |
| 2014-06-30 | $1.00B 10-K · filed 2015-03-02 |
| 2013-06-28 | $707.00M 10-K · filed 2014-02-28 |
| 2012-06-30 | $784.50M 10-K · filed 2013-03-01 |
| 2011-06-30 | $581.90M 10-K · filed 2012-03-12 |
| 2010-06-30 | $506.90M 10-Q · filed 2011-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |